TY - JOUR
T1 - Managing risks of TNF inhibitors
T2 - An update for the internist
AU - Hadam, Jennifer
AU - Aoun, Elie
AU - Clarke, Kofi
AU - Wasko, Mary Chester
PY - 2014/2
Y1 - 2014/2
N2 - Tumor necrosis factor (TNF) inhibitors have many beneficial effects, but they also pose infrequent but significant risks, including serious infection and malignancy. These risks can be minimized by judicious patient selection, appropriate screening, careful monitoring during treatment, and close communication between primary care physicians and subspecialists.
AB - Tumor necrosis factor (TNF) inhibitors have many beneficial effects, but they also pose infrequent but significant risks, including serious infection and malignancy. These risks can be minimized by judicious patient selection, appropriate screening, careful monitoring during treatment, and close communication between primary care physicians and subspecialists.
UR - http://www.scopus.com/inward/record.url?scp=84893914926&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84893914926&partnerID=8YFLogxK
U2 - 10.3949/ccjm.81a.12121
DO - 10.3949/ccjm.81a.12121
M3 - Review article
C2 - 24493494
AN - SCOPUS:84893914926
SN - 0891-1150
VL - 81
SP - 115
EP - 127
JO - Cleveland Clinic journal of medicine
JF - Cleveland Clinic journal of medicine
IS - 2
ER -